Chicago, IL

Visit us at the ENDO 2023 Annual Meeting and learn how the largest gene and fusion panel available has become part of Afirma GSC, along with the added capability of TERT DNA analysis.

Data being presented during the conference:

Thursday, June 15^th 12:30-1:30 PM CT
Dr. Sina Jasim is presenting a poster titled, “Cytologic and Molecular Assessment of Isthmus Thyroid Nodules.”
Location: THU-680

Saturday, June 17^th 8:00-9:30 AM CT
Managing Lumps and Bumps in the Thyroid
Dr. Joshua Klopper will participate in a panel discussion about “the use of various molecular tests and markers to distinguish and stratify patients with benign and malignant nodules” as part of the “Managing Lumps and Bumps in the Thyroid” session.
Location: W-181

Saturday, June 17^th 1:00-2:00 PM CT
Dr. Priyanka Iyer is presenting a poster titled, “Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay.”
Location: SAT-630

Sunday, June 18^th 8:00-9:30 AM CT
Predicting Thyroid Malignancy: What Tools Do We Have?
Dr. Allan Golding will be presenting a study titled, “mRNA Expression Based Tumor Behavior Prediction Models in Thyroid Nodules.”
Location: W-176

We will be available at booth #1509 to answer any questions.

We invite you to join our live discussion looking at how intrinsic molecular subtypes can help guide therapeutic decisions. 

The presentation will be supported by clinical case discussions with: 

• Pr Frédérique Penault-Llorca
• Pr Gilles Freyer 
• Dr Olivier Tredan

Berlin, Germany

Onsite and virtual  

Meet our team in Berlin to learn how Prosigna Breast Cancer Assay was developed from the four PAM50 intrinsic subtypes and provides better prognostic accuracy.

If you would like to book a meeting with the Veracyte team during ESMO Breast, please use the BOOK A MEETING link below.

Seattle, WA

Visit us at the AACE Annual Meeting and learn how the largest gene and fusion panel available has become a part of Afirma GSC with the added capability of TERT DNA analysis.

Jessica Pinto, MD will present a poster titled “Histopathology of Telomerase Reverse Transcriptase

Promoter (TERT) Mutated Indeterminate Thyroid Nodules” on Friday, May 5, 2023 from 10:25 am – 10:40 am PT. Location: The Poster Experience - Summit Building - Level 2.

In addition, there are other opportunities to engage with the Afirma team:

Join us for a cocktail reception on Friday, May 5^th from 5:00 – 7:00 pm PT at The Nest Rooftop Bar (110 Stewart Street, Seattle WA 98101), as we recognize the positive impact of molecular testing on patients with thyroid nodules.

We will be available at booth #220 to answer any questions. 

Vienna, Austria

Visit us at booth #13 during the St.Gallen International Breast Cancer Conference 2023 to learn how the Prosigna Breast Cancer Assay was developed from the four PAM50 intrinsic subtypes and provides better prognostic accuracy and improves treatment decisions. 

If you would like to book a meeting with the Veracyte’s Prosigna team, please submit a request and we will be in touch.

London, UK

Meet with us in London to learn how our Biopharma Services team can help you confidently advance your oncology drug development programs. If you would like to meet with the Veracyte team during Next-Gen Immuno-Oncology Conference, please book an in-person or virtual meeting.

We are also delighted to host a presentation at the meeting entitled, "The Veracyte Biopharma Atlas, A Comprehensive Cancer Reference Database," with Valérie Balme, Ph.D., Associate Director, Business Development for Biopharma Services at Veracyte.
Don’t miss this presentation and the opportunity to learn more about the Veracyte Biopharma Atlas and how it can help clinical researchers maximize the value of the data generated through our Immunogram analysis platform. 

Miami Beach, FL

Visit us at booth #1 to learn about the new US Prosigna patient report and how the Prosigna Gene Signature Assay provides more comprehensive information to better inform treatment decisions.

If you would like to book a meeting with Veracyte’s Prosigna team, please submit a request and we will be in touch.

San Francisco & Online

Meet with our Decipher Urologic Cancers and Biopharma Services teams at ASCO GU!
We will be at Booth #46 throughout the conference. Come join us to learn more about our Decipher Prostate and Decipher Bladder genomic classifiers, as well as how our Decipher GRID RWD offering can help support biopharma partners in their drug development program

Brooklyn, NY

Meet with our Biopharma Services team in New York at Immuno-Oncology 360° to learn how you can gain actionable insights to confidently advance your oncology and immuno-oncology drug development programs.

Virtual

Meet with our Biopharma Services team to learn how we can help you confidently advance every step of your oncology drug development programs.

Montreal, Quebec, Canada

Visit us at the ATA meeting and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules. Data being presented at the meeting include:

• Visit us at the ATA meeting and learn how Afirma genomic testing can help you diagnose and create the best treatment plan for your patients with thyroid nodules. Data being presented at the meeting include:

  • John Phay, MD presenting a study titled “Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules (ITN) Harboring Thyroid Stimulating Hormone Receptor (TSHR) Mutations” on Friday, October 21st. This presentation will be within the session titled “Friday Afternoon Clinical Oral Abstracts - Pediatrics, Thyroid Nodules and Goiter” from 2:45pm – 4pm EDT
  • Joshua Klopper, MD presenting a poster titled “Thyroid Nodule Risk Stratification: mRNA Expression Based Tumor Behavior Prediction Models” on Thursday, October 20^th. This poster will be within the late breaking posters from 10:30am – 4:30pm.

In addition, there are other opportunities to engage with the Afirma team:

• • Join us for a cocktail reception on Thursday, Oct 20^th from 6:30-8:30pm at Sauvage (52 Rue Saint-Jacques), as we recognize the positive impact of molecular testing on patients with thyroid nodules - Create a reminder on your calendar
  • We will be available at booth #911 to answer any questions. If you would like to book a meeting with the Afirma team, please submit a request and we will be in touch. Book a meeting

New Orleans, LA

Visit us at the CAP meeting and learn how Veracyte’s products can help you and your patients.

• Join us for a cocktail reception on Sunday, October 9^th, from 6:30 - 8:30pm CDT as we recognize the positive impact of molecular testing on patients with thyroid nodules - Create a reminder on your calendar 
• We will be available at our booth to answer any questions. If you would like to book a meeting with the Afirma team, please submit a request we will be in touch. Book a meeting

• Understand the history and origin of PAM50 & Prosigna
• Discuss their evolution from the laboratory to the clinic
• Learn how accurate biological classification can be used to best treat your patients

Philadelphia, PA

Visit us at the AAO-HNSF meeting and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules.

• Join us for a cocktail reception on Sunday September 11^th, from 6:30-8:30pm EDT in The Gallery in the Le Meridien hotel, as we celebrate the impact of molecular testing on patients with thyroid nodules. Create a reminder on your calendar 
• We will be available at booth #2011 to answer any questions. If you would like to book a meeting with the Afirma team, please submit a request we will be in touch. Book a meeting

• Understand the potential of Prosigna
• Discuss the advantages of using a second-generation genomic test
• Learn about the utility of intrinsic subtyping in the clinic

Visit us at the AAES meeting and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules. We will be available at booth #102 to answer any questions. If you would like to book a meeting with the Afirma team, you can submit a request using the link below and we will be in touch.

Book a meeting

Veracyte has also sponsored an on demand webinar. Listen as Joshua Klopper, MD discusses the clinical performance of the Afirma Genomic Sequencing Classifier and how it can help optimize thyroid nodule management. The webinar can be accessed using the link below:

Clinical Performance of the Afirma Genomic Sequencing Classifier: Real World Experience and the Optimization of Thyroid Nodule Management

San Franscisco, California

Visit us at Booth 1908 to learn about our genomic diagnostic tests of interstitial lung disease and lung cancer. LEARN MORE

Join our ATS Industry Theaters

• Tuesday, May 17, 12:30-1:00pm - Integrating Novel Genomic Data to Improve ILD Dagnositc and Prognostic Confidence
  • Create a reminder on your Google Calendar
  • Create a reminder on your Outlook Calendar
• Tuesday, May 17, 1:30-2:00pm - Integrating the Percepta Genomic Sequencing Classifier for Lung Nodules and Risk Stratification 
  • Create a reminder on your Google Calendar
  • Create a reminder on your Outlook Calendar 

Data Presentation

• Monday, May 16, 9:30-11:00am - Poster #217: A Nasal Genomic Classifier for Assessing Risk of Malignancy In Lung Nodules Demonstrates Similar Performance In Patients that Meet Screening Criteria for High Baseline Risk and Those Who Do Not    

San Diego, California

Visit us at the AACE meeting and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules.

Data Presentations

• Saturday, May 14, 10:10am - Dorota Whitmer, MD will present a poster titled  “Malignancy Risk Associated with the Thyroid Stimulating Hormone Receptor (TSHR) pI568T Variant in Bethesda III/IV Thyroid Nodule Cytology” 
• Saturday May 14, 12:30pm - Joshua Klopper, MD will present “Clinical Performance of the Afirma Genomic Sequencing Classifier: Real World Experience and the Optimization of Thyroid Nodule Management” 

Additional opportunities to engage with the Afirma team

• Friday May 13 Cocktail Reception, 5:00-7:00pm in the Presidential Suite (#3001) of the AACE conference hotel, the Hilton San Diego Bayfront, as we celebrate the impact of molecular testing on patients with thyroid nodules - Create a reminder on your calendar 
• If you would like to book a meeting with the Afirma team, please submit a request we will be in touch. Book a meeting

Dallas, Texas

Visit us at the AHNS annual meeting and learn how Afirma genomic testing can help you confidently guide diagnosis, and guide surgery and treatment decisions for patients with thyroid nodules.

We will be available at booth #501 to answer any questions.

A new on-demand webinar, sponsored by Veracyte, is available via the American Thyroid Association (ATA). Watch as a multidisciplinary panel from leading institutions across the country discusses the expanding role of tumor genotyping in thyroid nodule patient management. This discussion, led by Dr. Paul Ladenson, features several real-world case studies from the perspectives of an endocrinologist, surgeon, and pathologist.

This interactive session covers the key elements of an MDD, the role of the Envisia genomic classifier, and the identification of progressive fibrosing ILD.

Experts review how the Percepta and Envisia genomic classifiers help improve confidence in lung disease diagnosis and share how the tests integrate into their patient management.